We are live on
!
Find out more
NewAmsterdam Pharma
NAMS
NAMS
137 hedge funds and large institutions have $3.42B invested in NewAmsterdam Pharma in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.41% more ownership
Funds ownership: 103.65% → 107.06% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
96% less call options, than puts
Call options by funds: $2.48M | Put options by funds: $69.2M
Holders
137
Holding in Top 10
7
Calls
$2.48M
Puts
$69.2M
Top Buyers
| 1 | +$87M | |
| 2 | +$34.4M | |
| 3 | +$30M | |
| 4 |
DFO
Duquesne Family Office
New York
|
+$26.2M |
| 5 |
Morgan Stanley
New York
|
+$20.6M |
Top Sellers
| 1 | -$34M | |
| 2 | -$20.4M | |
| 3 | -$17.7M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$12.6M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$12.1M |